[1]Si Y, Bao H, Han L, et al. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation[J]. J Transl Med, 2013, 11: 141.doi:10.1186/1479-5876-11-141. [2]Li J, Chen Q, He X, et al. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α2AR/PI3K/Akt pathway[J]. J Transl Med, 2018, 16:78.doi:10.1186/S12967-018-1455-1. [3]曾敏, 杨定平, 朱凯. 线粒体Surtuin3在急性肾损伤中的作用研究进展[J]. 临床肾脏病杂志, 2018, 18: 645-648. [4]Pi H, Xu S, Reiter RJ, et al. SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin[J]. Autophagy, 2015, 11: 1037-1051. [5]Salvatori I, Valle C, Ferri A, et al. SIRT3 and mitochondrial metabolism in neurodegenerative diseases[J]. Neurochem Int, 2017, 109: 184-192. [6]Guan Y, Cui ZJ, Sun B, et al. Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1α-SIRT3 signaling pathway[J]. Int J Mol Med, 2016, 37: 1229-1238. [7]Koyama T, Kume S, Koya D, et al. SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells[J]. Free Radic Biol Med, 2011, 51: 1258-1267. [8]Emma F, Montini G, Parikh SM, et al. Mitochondrial dysfunction in inherited renal disease and acute kidney injury[J]. Nat Rev Nephrol, 2016, 12: 267-280. [9]Morigi M, Perico L, Rota C, et al. Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury[J]. J Clin Invest, 2015, 125: 715-726. [10]Ying Y, Padanilam BJ. Regulation of necrotic cell death: p53, PARP1 and cyclophilin D-overlapping pathways of regulated necrosis[J]. Cell Mol Life Sci, 2016, 73: 2309-2324. [11]周四桂, 徐立朋, 廖端芳, 等. 环孢霉素A通过ROS-Cyclophilin A-ERK1/2信号途径抑制人脐静脉内皮细胞与中性粒细胞粘附[J]. 生理学报, 2004, 56: 313-320. |